Wu, Thomas
Genentech, Inc,
United States
2024 Rank: 89164
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Bioinformatics
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 271 out of 22293 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 89164 | 98543 |
| Total Cites | 1030 | 1052 |
| H-index | 15 | 16 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 351 | 354 |
| Number of Single+First+Last Authored Papers | 20 | 20 |
| Total Cites to Single+First+Last Authored Papers | 358 | 361 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 988 | 1005 |
| Ratio of Total Citations to Distinct Citing Papers | 1.04 | 1.05 |
| Self-Citation Percentage |
2.09%
|
|
Wu, Thomas
Genentech, Inc,
United States
2023 Rank: 76845
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Bioinformatics
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 246 out of 21123 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 76845 | 85551 |
| Total Cites | 1069 | 1107 |
| H-index | 15 | 16 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 375 | 378 |
| Number of Single+First+Last Authored Papers | 20 | 20 |
| Total Cites to Single+First+Last Authored Papers | 380 | 383 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1023 | 1050 |
| Ratio of Total Citations to Distinct Citing Papers | 1.04 | 1.05 |
| Self-Citation Percentage |
3.43%
|
|
Wu, Thomas
Genentech Incorporated,
United States
2022 Rank: 72917
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Bioinformatics
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 233 out of 20000 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 72917 | 85359 |
| Total Cites | 1170 | 1203 |
| H-index | 15 | 15 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 417 | 423 |
| Number of Single+First+Last Authored Papers | 20 | 20 |
| Total Cites to Single+First+Last Authored Papers | 427 | 433 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1137 | 1165 |
| Ratio of Total Citations to Distinct Citing Papers | 1.03 | 1.03 |
| Self-Citation Percentage |
2.74%
|
|
Wu, Thomas
Genentech Incorporated,
United States
2021 Rank: 76439
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Bioinformatics
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 198 out of 19302 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 76439 | 86332 |
| Total Cites | 1676 | 1731 |
| H-index | 17 | 17 |
| Hm-index | 2 | 3 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 581 | 583 |
| Number of Single+First+Last Authored Papers | 20 | 20 |
| Total Cites to Single+First+Last Authored Papers | 596 | 598 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1616 | 1659 |
| Ratio of Total Citations to Distinct Citing Papers | 1.04 | 1.04 |
| Self-Citation Percentage |
3.18%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.